I think the most important piece of the news today is:

"We are completing the audit of the 2016 Annual Report, focused on building new relationships with doctors, clinics, and long term care facilities, and pushing forward on our aggressive growth agenda. We are emboldened by the new opportunities we have in front of us, like our Century Village Resource Center and Smart Medical Alliance and are looking forward to strong results from both of these ventures this year."

Of course, I should make sure next time I check my grammar before posting! It seems I am keen on grammatical mistakes when I multitask.

If I run across more recipes ill be sure to share. I know with all the connoisseurs here that it would be remiss of me not to.

I definitely will. I have been trying root beers lately and been through about 5 different brands. I am not a fan of their flavor profiles alone but when I make beer floats they are indispensable.

I imagine you could make a beer float with the ginger beer with a pistachio rosewater ice cream.

Looking at ginger beer within a 200 mile radius of where I live I found these little gems as well. The latter has some recipes I suggest you !

http://rachelsgingerbeer.com/collections/shop

http://portlandgingerbrew.com/

and it looks like Gosling gets kudos in this blog- I would expect more praise is it gets into more hands.

http://www.loveandoliveoil.com/2014/12/11-best-ginger-beers.html

For ethical reasons I do not shop at Walmart :( However I am in a state that prides itself on micro brews and liquors so I imagine I will be able to find it.

This was a nice surprise to wake up to this morning. This has been a great little gem to run into so I have to give you some credit Soldier, thank you for putting this on my radar. Congrats everyone on the nice news today. What do you all think we will see as far as price action goes today and a month from now?

Also, has anyone tried the beer I am curious where I can find myself some!

I do not disagree with that information about BIEL. I imagine the cost of production for each product (hard costs) are about 1-5 dollars at most. My comment was more in reference to the retailers. Also, they need to talk to health organizations about the reduction in opiates. Most large health organizations are looking for alternative solutions to pain treatment. It would be nice to see if they are working on doing contractual work with ACO/HMO/CCO's to get it as an approved item that patients do not need to pay OOP for.

A very reasonable response. I tend to align my thoughts in the same manner however I think a round of dilution may occur to ensure capital for logistics which I am fine with. I would hope the company starts to buy back shares after and retire them.

Thank you John for checking in with the company. I am curious what is going on behind the scenes. It appears their is probably a lot of changes going on especially after the MIDAM situation and the CEO letter.

Just maybe it has to do with Donald Trump "respecting" states decision to legalize it. I am surprised all those companies publicly traded have not gone down 50%+.

https://www.forbes.com/sites/julieweed/2017/02/25/5-things-donald-trump-needs-to-know-before-he-destroys-the-legal-marijuana-industry/#4087a6ff44e8

Do you know where PMCB is at regards to this business line?

I just bought a small amount, slowly accumulating.

That's all great news but lets look at it more objectively. What are the department profit margins? I bet you the medications are the primary profit driving business line.

It's a bit sad that we do not have more in depth discussions about their business model ect.

JMHO

Here are a few of the technologies being explored to help with the opiate epidemic. Oregon and Washington have had a huge influx of new heroine users and both states law makers have made it a priority to reduce the opiates prescribed. They have a specific formula which if I recall right is morphine equivalents and they need to stay under a specific number.

https://www.sciencedaily.com/releases/2015/09/150910141331.htm

https://fas.org/sgp/crs/misc/R42593.pdf

http://www.oregonlive.com/health/index.ssf/2011/07/oregons_prescription_tracking.html

https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm

A social influencer would be a better investment to market this product. They have more of a built in trust with their audience.

Thank you for giving me this info I appreciate it!

So I am digging into the publish financials of the company and I am curious what everyone's take is on the company's finances.

Some things that stick out to me are:

The Company’s Try & Tell sales and marketing 7-Day trial device
campaign has won the OTC Bulletin’s 2015 “Best OTC Marketing Campaign on a Small Budget” award. Current chronic pain therapies do not meet the need for chronic pain relief and sufferers are skeptical. To overcome the skepticism and accelerate product acceptance, we promote a discounted 7-Day Trial device without an on/off switch. 65% of testers averaged a 57% reduction in pain and said they “intended” to or would “maybe” purchase and 80% did purchase an average of 1.75 devices within 90-days. After one year, the users purchased an average of 2.7 devices.

This bodes well for the commercialization of this product through large chain stores and aggressive marketing.

Moving on into the contracts they have through their lenders could someone with a bit more background knowledge inform me of how this might be reconciled? Has the CEO spoken to the high number of shares, when they hope to be cash flow positive, and other information I may have missed? What is are their current sales look like in comparison with years 09'-15'?

Thanks in advance!

I agree 110%

I must of missed that. I will go peek at it, thanks.

Yup, they need to purchase some stocks/retire some. This is the only way I see this moving forward in the short term. It appears there is something functionally wrong with this stock especially if they "report" being in the black.

I own shares and have a time frame but other folks that are looking at investing in this will be turned off by the prexisting history. They need to build more confidence.

Look at that little double post I did.

It appears I posted right after Times-

Thanks for the update.

I think we will bounce back up into the high 2's or maybe get back to the baseline of where it has been trading at in the 3's. Just my best guess :P

Speculation, NWBO is in phase 3 clinical trials. It has 60% chance of going to a new drug application at which time it will be about 85% sure of approval. The market is illogical because traders trade off emotion.

Do we know when earnings will be out for INNV?

I found this one as I did some stock screening on my day off. I am considering picking up 300k-1million shares tomorrow if all things go as planned.

I am new to this stock and new to this board so I have a lot of DD still to do today however is there plans on getting health plans to reimburse for this product? Do we know if they are actively doing trade shows? Has the company worked with pain clinics? It's a big deal as the trend is to ween folks off opiates and prescribers are much more likely to look for alternative therapies which might help also drive this market.


Anyways hello everyone!

Fascinating that I wanted to drop in and say hello to all of you only to find out there is an Administrative Warning placed on this board, whoa now!

Anyways, I am considering picking up a small position in this company after I do some more DD, but having a reasonable success rate with my investments, I can take on it's high risk. I ran into this little bugger via a stock screener and it caught my attention.

I am not sure if all of you have been exposed to the FDA approval rates based on what phase and type of product is being reviewed but to add a possible new perspective here are some good reads. Phase 3 have a high probability for approval.

http://www.nature.com/nbt/journal/v32/n1/box/nbt.2786_BX2.html

https://www.bio.org/sites/default/files/Clinical%20Development%20Success%20Rates%202006-2015%20-%20BIO,%20Biomedtracker,%20Amplion%202016.pdf

"Oncology drugs had a 2x higher rate of first cycle approval than Psychiatric drugs, which had the lowest percent
of first-cycle review approvals. Oncology drugs were also approved the fastest of all 14 disease areas."

It appears depending on the classification of their product it has a greater than 50% chance of approval.

I look forward to reading more on what you all add. It seems like this one is a gamble running against the clock.

It appears I should update the board. Anything you would like added?

I would be shocked if they didnt. One of the books I read called "Intro to Healthcare Economics" had some interest statements about the diffusion of technology. Not to bore you all with the economics of it or the more technical aspects of adopting technology but here is a great read about it.

https://www.nap.edu/read/1810/chapter/3#22

I conclude by saying if they can add new tech without it being a liability I think it's a great idea but you need to ensure that positive benefits outweigh the risks and sometimes business do not do that.

I have always been curious how this compares to other Pharmacies with similar amount of employees and costumer base. I haven't been able to find data on it but it would be interesting to know none the less.

Yes it is, I think we should see about a 20 cent gain per share within the next few weeks. It has excellent support right now.

Also, we will know a lot more about their survival status after audits. There are to many unknowns hence why it's on the pinks.

Tell that to the CEO of the company. She said it herself how these changes could impact them or do you live in an alternative facts universe?

Maybe you are not aware of how reimbursements work and CCO/ACO/MCO. It's pretty common knowledge that those who get served from these types of companies and their services will be impacted. The CEO is aware of that reality to. If you have an issue with the reality I suggest you contact Ms. Mars and ask her what do they have in place to substitute uncle sams reimbursement when it gets s gutted.

However, there has already been hiring freezes and an industry pullback because the threat.



http://www.modernhealthcare.com/article/20161109/NEWS/161109911

http://www.kgw.com/news/health/as-obamacare-repeal-looms-ohsu-to-significantly-reduce-hiring/385597527

It's interesting to see that the stock price is inverted of where you would expect it to go after the CEO puts out an investor statement. I think audits and retiring shares/insider buying will be the only way to increase SP substantially at this point.

It's the culture. I work within that field and usually untested tech such as this are not on anyone's radar. This is a new technology delivering the same medication so my assumption is there is very little pressure until more clinical evidence is present.

Thank you both for your responses. I am excited to watch this stock as I am long in it. I was thinking of doing some swing trading but I am not that committed yet!

A quick question for everyone here and I it's all speculation but what if all ducks line up. AMD has a nice payday from Google and AliBaba, ZEN sales are through the roof, and Vega delivers.

What would you project the share price be in 1 year and would it possible to see a split down the road as just a 2% market of the server market would be enormous.

Again- I know it's speculation but I like to fantasize.

Even though I think you are too optimistic, and occasionally a bit fanatical, I am looking forward to see what you are talking about.

Thanks for always keeping it civil Honey

All very rational thoughts, I concur.

I think Donald Trump is a poor example. You should reconsider your statement as he is liable, has little support, and buyers remorse is what you think if you had first invested in him.

I think I will put a bid in for .015 for 200k shares. I think that is reasonable at this time as there is no support and there are chances this will crash down there on occasion.

That's nice to hear. Especially since I know what kind of pain it can be from personally helping in research myself.